These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1132912)

  • 1. Quantity and avidity of antibodies against birch pollen in atopic patients during hyposensitization. A preliminary study.
    Ahlstedt S; Belin L; Eriksson NE; Hanson LA
    Int Arch Allergy Appl Immunol; 1975; 48(5):632-41. PubMed ID: 1132912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of specific IgE antibodies in sera of Japanese birch-allergic patients using recombinant allergens Bet v 1, Bet v 2 and Bet v 4.
    Shirasaki H; Yamamoto T; Koyanagi Y; Watanabe N; Himi T
    Allergol Int; 2008 Mar; 57(1):93-6. PubMed ID: 18209509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hyposensitization for tree pollinosis on associated apple allergy.
    Herrmann D; Henzgen M; Frank E; Rudeschko O; Jäger L
    J Investig Allergol Clin Immunol; 1995; 5(5):259-67. PubMed ID: 8574432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [IgE and IgG antibody response in patients with type I allergy to birch pollen].
    Rumpold H; Jarolim E; Bonitz W; Tejkl M; Breitenbach M; Scheiner O; Kraft D
    Wien Klin Wochenschr; 1989 Feb; 101(3):107-10. PubMed ID: 2922932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different IgE reactivity profiles in birch pollen-sensitive patients from six European populations revealed by recombinant allergens: an imprint of local sensitization.
    Movérare R; Westritschnig K; Svensson M; Hayek B; Bende M; Pauli G; Sorva R; Haahtela T; Valenta R; Elfman L
    Int Arch Allergy Immunol; 2002 Aug; 128(4):325-35. PubMed ID: 12218371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High correlation of specific IgE sensitization between birch pollen, soy and apple allergens indicates pollen-food allergy syndrome among birch pollen allergic patients in northern China.
    Hao GD; Zheng YW; Wang ZX; Kong XA; Song ZJ; Lai XX; Spangfort MD
    J Zhejiang Univ Sci B; 2016 May; 17(5):399-404. PubMed ID: 27143268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
    Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
    Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interleukin 4, total and allergen-specific immunoglobulin E antibodies in the blood of individuals with an atopic constitution].
    Paranos S; Pravica V; Bonaci B; Stojković-Mostarica M
    Srp Arh Celok Lek; 1998; 126(3-4):92-6. PubMed ID: 9863362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of anti-IgE treatment on in vitro leukotriene release in children with seasonal allergic rhinitis.
    Kopp MV; Brauburger J; Riedinger F; Beischer D; Ihorst G; Kamin W; Zielen S; Bez ; Friedrichs F; Von Berg A; Gerhold K; Hamelmann E; Hultsch ; Kuehr J
    J Allergy Clin Immunol; 2002 Nov; 110(5):728-35. PubMed ID: 12417881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complexes of grass pollen allergens and specific antibodies reduce allergic symptoms and inhibit the seasonal increase of IgE antibody.
    Machiels JJ; Buche M; Somville MA; Jacquemin MG; Saint-Remy JM
    Clin Exp Allergy; 1990 Nov; 20(6):653-60. PubMed ID: 2083405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy in spring-time hay fever. A clinical and immunological study comparing two different treatment extract compositions.
    Eriksson NE; Ahlstedt S; Lövhagen O
    Allergy; 1979 Aug; 34(4):233-47. PubMed ID: 92897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
    Möbs C; Ipsen H; Mayer L; Slotosch C; Petersen A; Würtzen PA; Hertl M; Pfützner W
    J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation of allergen-specific IgE and IgA responses in sera and tears of pollen-allergic patients: a study performed with purified recombinant pollen allergens.
    Aghayan-Ugurluoglu R; Ball T; Vrtala S; Schweiger C; Kraft D; Valenta R
    J Allergy Clin Immunol; 2000 Apr; 105(4):803-13. PubMed ID: 10756233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic changes during specific treatment of the atopic state. 3. The immunologic response in the course of hyposensitization of hay fever patients with aqueous and alum - pyridine allergens.
    Zavázal V; Stajner A
    Acta Allergol; 1970 Apr; 25(1):18-24. PubMed ID: 5468237
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen-related apple allergy.
    Kinaciyan T; Nagl B; Faustmann S; Frommlet F; Kopp S; Wolkersdorfer M; Wöhrl S; Bastl K; Huber H; Berger U; Bohle B
    J Allergy Clin Immunol; 2018 Mar; 141(3):1002-1008. PubMed ID: 28870463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin test results but not serology reflect immediate type respiratory sensitivity: a study performed with recombinant allergen molecules.
    Niederberger V; Stübner P; Spitzauer S; Kraft D; Valenta R; Ehrenberger K; Horak F
    J Invest Dermatol; 2001 Oct; 117(4):848-51. PubMed ID: 11676821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin G4-antibodies to rBet v 1 and risk of sensitization and atopic disease in the child.
    Kihlström A; Hedlin G; Pershagen G; Troye-Blomberg M; Härfast B; Lilja G
    Clin Exp Allergy; 2005 Dec; 35(12):1542-9. PubMed ID: 16393319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Clinical Impact of Bet v 6 in Birch Pollen-Sensitized Patients.
    Gellrich D; Eder K; San Nicoló M; Berghaus A; Gröger M
    Int Arch Allergy Immunol; 2017; 173(1):34-43. PubMed ID: 28494455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the antibody responses induced by subcutaneous injection immunotherapy with birch and Fagales pollen extracts adsorbed onto aluminum hydroxide.
    Gadermaier E; Flicker S; Aberer W; Egger C; Reider N; Focke M; Vrtala S; Kundi M; Valenta R
    Int Arch Allergy Immunol; 2010; 151(1):17-27. PubMed ID: 19672093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.